Successful Treatment of CAPD Peritonitis Caused by Moraxella Catarrhalis

Open access


Peritonitis remains a major complication of peritoneal dialysis which is usually caused by saprophytic gram positive microorganisms originated from skin. Here, I report an unusual case of peritonitis due to Moraxella catarrhalis.

A male, 59 age, on peritoneal dialysis modality because ESRD due to diabetic nephropathy was admitted to our hospital due to CAPD peritonitis. After initial empiric treatment and identification of this infrequent causer, he was submitted to two week antibiotic treatment with complete recovery and good prognosis.

Peritonitis is the major cause of peritoneal dialysis failure which requires prompt recognition of the causative agent for successful treatment.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Lameire N Van Biesen W Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end –stage renal disease. Peritoneal Dialysis International. 2000;20(2):S134-141.

  • 2. Li PK Szeto CC Piraino B et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016;36:481-508.

  • 3. Holley JL Praino BM. Complications of peritoneal dialysis: Diagnosis and management. Semin Dial. 1990;3:245.

  • 4. Woodrow G Turney JH Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17:360.

  • 5. Perez Fontan M Rodriguez-Carmona A Garcia-Naveiro R et al. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274.

  • 6. Akoh JA. Peritoneal dialysis associated infections: An update on diagnosis and management. World J Nephrol. 2012;1(4):106–122.

  • 7. MacArthru RD. Branhamella Catarrhalis peritonitis in two continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1990;10:169–71.

  • 8. Dadone C Redaelli B. Branhamella Catarrhalis peritonitis in CAPD: An avoidable complication. Perit Dial Int. 1991;11:185.

  • 9. Contreras MR Ash SR Swick SD Grutzner J. Peritonitis due to Moraxella Catarrhalis(Branhamella) in a diabetic patient receiving peritoneal dialysis. South Med J. 1993;86:589–90.

  • 10. Ragnaud JM Bezian MC Marceau DM Wone C. Treatment of peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal ceftriaxone. Pathol Biol. 1988;36(5):552–56.

  • 11. Fandos JMG Manez MB. Peritonitis Due to Moraxella Non Liquefaciens. Perit Dial Int. 2014; 34(6): 674–675.

  • 12. Badrising S Bakker L Lobatto S Van Es A. Peritonitis in a Peritoneal Dialysis Patient Due to Rhizobium radiobacter and Moraxella osleonsis: Case Report and Literature Review. Perit Dial Int. 2014; 34(7): 813–815.

  • 13. Sadjadi SA Obedoza P Annamarju P. Moraxella Catarrhalis peritonitis. Am J Case Rep. 2012;13:19–21.

  • 14. Verduin CM Hol C Fleer A at al. Moraxella catarrhalis: from emerging to established pathogen. Clinical Microbiology Reviews 2002;15(1):125-144.

  • 15. Ryan KJ Ray CG. Sherris Medical Microbiology: An Introduction to Infectious Disease. 4th ed. New York McGraw-Hill; 2004.

  • 16. Garrity GM Brenner DJ Krieg NR and Staley JT (Eds.). Bergey’s Manual of Systematic Bacteriology. 2nd ed. New York: Springer; 2005.

  • 17. Murray PR Baron EJ Jorgensen JH Landry ML and Pfaller MA (Eds.). Manual of Clinical Microbiology. 9th ed. Washington: ASM Press; 2007.

  • 18. Buchanan BK. Moraxella branhamella Kingella and Aeikenella. In: Balows A. and Duerden BI (Eds). Topley and Wilson’s Microbiology and Microbial Infections. 1998. P1139-46.

  • 19. Tritton D Watts T Sieratzki JS. Peri-orbital cellulitis and sepsis by Branhamella catarrhalis. Eur J Pediatr. 1998;157(7):611-2.

  • 20. Abdolrasouli A Amin A Baharsefat M et al. Moraxella catarrhalis associated with acute urethritis imitating gonorrhoea acquired by oral-genital contact. Int J STD AIDS. Aug. 2007;18(8):579-80.

  • 21. Jorgensen JH Doern GV Maher LA et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae Moraxella catarrhalis and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy. 1990;34(11):2075-2080.

Journal information
Impact Factor

CiteScore 2018: 0.13

SCImago Journal Rank (SJR) 2018: 0.118
Source Normalized Impact per Paper (SNIP) 2018: 0.079

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 248 142 4
PDF Downloads 146 91 6